Jpmorgan Chase & CO Lifevantage Corp Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Lifevantage Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 997 shares of LFVN stock, worth $16,560. This represents 0.0% of its overall portfolio holdings.
Number of Shares
997
Previous 997
-0.0%
Holding current value
$16,560
Previous $6,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding LFVN
# of Institutions
74Shares Held
3.85MCall Options Held
43.5KPut Options Held
2.3K-
Jim Simons Renaissance Technologies LLC | New York, Ny828KShares$13.8 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA498KShares$8.27 Million0.0% of portfolio
-
Capital Management Corp420KShares$6.98 Million1.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX296KShares$4.92 Million0.0% of portfolio
-
Envestnet Asset Management Inc223KShares$3.7 Million0.0% of portfolio
About Lifevantage Corp
- Ticker LFVN
- Exchange NASDAQ
- Sector Consumer Defensive
- Industry Packaged Foods
- Shares Outstandng 12,560,000
- Market Cap $209M
- Description
- LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...